Diagnosing HIV in resource-limited settings
In this blog, we discuss the need for improved point-of-care (PoC) diagnostics for HIV and present the virus’s cellular mechanism to illustrate our new range of HIV antigens and antibodies. HIV in the developed world On June 5th 1981 in Los Angeles, California,...
Green Science
We don’t need to lay out the case for climate change, loss of biodiversity or plastic pollution; the wealth of evidence from our scientific colleagues studying this is both compelling and accepted world-wide. The bigger question really is: what can we do to stop it?...
Our Product Pipeline
If you’ve been following us on social media recently, you might have noticed that we’ve been releasing a lot of new antigens and antibodies. In this blog, we explain how we use the WHO R&D Blueprint to guide our product development and present some highlights from...